000 | 02003 a2200565 4500 | ||
---|---|---|---|
005 | 20250516202720.0 | ||
264 | 0 | _c20150102 | |
008 | 201501s 0 0 eng d | ||
022 | _a1538-8514 | ||
024 | 7 |
_a10.1158/1535-7163.MCT-13-0731 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCampbell, Veronica T | |
245 | 0 | 0 |
_aHedgehog pathway inhibition in chondrosarcoma using the smoothened inhibitor IPI-926 directly inhibits sarcoma cell growth. _h[electronic resource] |
260 |
_bMolecular cancer therapeutics _cMay 2014 |
||
300 |
_a1259-69 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aADAMTS Proteins |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 |
_aCalcinosis _xdrug therapy |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aCell Proliferation |
650 | 0 | 4 |
_aChondrosarcoma _xgenetics |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aExtracellular Matrix Proteins _xgenetics |
650 | 0 | 4 |
_aHedgehog Proteins _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aReceptors, G-Protein-Coupled _xantagonists & inhibitors |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 | _aSmoothened Receptor |
650 | 0 | 4 |
_aTumor Burden _xdrug effects |
650 | 0 | 4 |
_aVeratrum Alkaloids _xadministration & dosage |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aNadesan, Puviindran | |
700 | 1 | _aAli, S Amanda | |
700 | 1 | _aWang, Chang Ye Yale | |
700 | 1 | _aWhetstone, Heather | |
700 | 1 | _aPoon, Raymond | |
700 | 1 | _aWei, Qingxia | |
700 | 1 | _aKeilty, John | |
700 | 1 | _aProctor, Jennifer | |
700 | 1 | _aWang, Lauren W | |
700 | 1 | _aApte, Suneel S | |
700 | 1 | _aMcGovern, Karen | |
700 | 1 | _aAlman, Benjamin A | |
700 | 1 | _aWunder, Jay S | |
773 | 0 |
_tMolecular cancer therapeutics _gvol. 13 _gno. 5 _gp. 1259-69 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/1535-7163.MCT-13-0731 _zAvailable from publisher's website |
999 |
_c23645299 _d23645299 |